[1] WENHAO W,JUNLAN F,HUANLONG Q,et al.Molecular therapy of colorectal cancer:progress and future directions[J].Int Cancer,2015,136(3):493.
[2] THAKKAR K,FISHMAN DS,GILGER MA.Colorectal polyps in childhood[J].Curr Opin Pediatr,2012,24(5):632.
[3] DESAI D,NUTAN D.Colorectal cancer surveillance in inflammatory bowel disease:a critical analysis[J].World J Gastrointest Endosc,2014,6(11):541.
[4] FEDYANIN M,TRYAKIN A,BYBARAVA A,et al.Maintenance therapy following first-line chemotherapy in metastatic colorectal cancer:toxicity and efficacy-single-institution experience[J].Med Oncol,2015,32(1):429.
[5] SHINTANI M,SANGAWA A,YAMAO N,et al.Smac/DIABLO expression in human gastrointestinal carcinoma:association with clinicopathological parameters and survivin expression[J].Oncol Lett,2014,8(6):2581.
[6] 张亚历,周殿元.重视肠镜检查方法,提高早期大肠癌的诊断水平[J].胃肠病学,2002,7(4):253.
[7] 周雪涛.内镜下早期大肠癌的诊断与治疗[J].中外医学研究,2011,9(26):161.
[8] QINGQUAN S,QIZHEN W,JIANKANG Z,et al.Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation[J].Chin Med J,2012,125(16):2841.
[9] 姜泊.染色内镜和放大内镜技术是提高早期大肠癌诊治水平的重要手段[J].第一军医大学学报,2002,22(5):385.
[10] 李国新,赵丽瑛.腹腔镜结直肠癌根治术解剖概要[J].中国实用外科杂志,2011(9):844.
[11] 朱建新.应用染色内镜和放大内镜提高内镜诊断水平[J].中华消化内镜杂志,2003,20(1):7.
[12] 季圣昉,钟捷,马天乐,等.色素放大结肠镜诊断结直肠隆起性病变的临床应用[J].中华消化杂志,2002,22(7):31.
[13] 黄响玲,钟祥柱,王曦钟,等.色素内镜在大肠早期肿瘤性病变诊断中的应用[J].广东医学院学报,2007,25(1):41.
[14] 甘晓协,张达容,刘预.CEA、CA19-9、TSGF在部分肿瘤诊断中的意义[J].国际检验医学杂志,2005,26(6):380.
[15] 张会涛,刘晓珺,沈滨,等.结直肠癌外周血肿瘤标志物的研究进展[J].世界华人消化杂志,2011(10):991.
[16] 赵己未,曾晖,邹冰,等.肿瘤标志物CEA、CA19-9在人结直肠癌检测中价值[J].现代消化及介入诊疗,2011,16(2):109.
[17] 杨冬.SURVIVIN与胃肠道恶性肿瘤[J].国际消化病杂志,2003,23(3):155.
[18] ROHAYEM J,DIESTELKOETTER P,WEIGLE B,et al.Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients[J].Cancer Res,2000,60(7):1815.